Get the Stockscreener App
222.96
2.52%
5.49
Overview
News
Price History
Option Chain
Financials
Why LRCX Down?
Discussions
Forecast
Stock Split
Dividend History
Lam Research Corp stock is traded at $222.96, with a volume of 14.35M.
It is up +2.52% in the last 24 hours and up +36.57% over the past month.
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
See More
Previous Close:
$217.47
Open:
$221.9
24h Volume:
14.35M
Relative Volume:
1.28
Market Cap:
$280.04B
Revenue:
$19.59B
Net Income/Loss:
$5.81B
P/E Ratio:
49.13
EPS:
4.538
Net Cash Flow:
$5.55B
1W Performance:
+2.11%
1M Performance:
+36.57%
6M Performance:
+122.14%
1Y Performance:
+181.44%
1-Day Range:
$219.00
$225.69
1-Week Range:
$206.61
$229.57
52-Week Range:
$56.32
$229.57
Lam Research Corp Stock (LRCX) Company Profile
Name
Lam Research Corp
Sector
Phone
(510) 659-0200
Address
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
222.96 | 273.15B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,358.57 | 516.86B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
327.01 | 253.01B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,567.82 | 203.00B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
228.15 | 35.66B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-15-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-23-25 | Reiterated | TD Cowen | Buy |
| Sep-30-25 | Initiated | HSBC Securities | Hold |
| Sep-29-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-22-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-02-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-14-25 | Resumed | Erste Group | Buy |
| Jul-31-25 | Downgrade | Summit Insights | Buy → Hold |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-10-25 | Initiated | Goldman | Buy |
| Apr-24-25 | Reiterated | TD Cowen | Buy |
| Mar-20-25 | Resumed | Oppenheimer | Outperform |
| Feb-20-25 | Upgrade | Susquehanna | Neutral → Positive |
| Jan-30-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-30-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-17-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-15-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-17-24 | Initiated | Cleveland Research | Neutral |
| Aug-01-24 | Reiterated | TD Cowen | Buy |
| May-13-24 | Initiated | Jefferies | Buy |
| Apr-25-24 | Reiterated | TD Cowen | Buy |
| Apr-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Apr-18-24 | Reiterated | Needham | Buy |
| Apr-16-24 | Initiated | Evercore ISI | Outperform |
| Apr-11-24 | Resumed | Deutsche Bank | Hold |
| Jan-25-24 | Reiterated | TD Cowen | Outperform |
| Jan-23-24 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-12-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-22-23 | Initiated | Redburn Atlantic | Buy |
| Oct-17-23 | Initiated | Raymond James | Outperform |
| Oct-13-23 | Upgrade | Needham | Hold → Buy |
| Sep-15-23 | Initiated | Wolfe Research | Outperform |
| Jul-24-23 | Reiterated | Mizuho | Buy |
| Jul-24-23 | Upgrade | Stifel | Hold → Buy |
| Apr-20-23 | Reiterated | Berenberg | Buy |
| Apr-20-23 | Reiterated | Evercore ISI | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Jefferies | Buy |
| Apr-20-23 | Reiterated | Mizuho | Buy |
| Apr-20-23 | Reiterated | Stifel | Hold |
| Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
| Mar-13-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-18-23 | Resumed | Stifel | Hold |
| Dec-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-20-22 | Reiterated | B. Riley Securities | Neutral |
| Oct-20-22 | Reiterated | BofA Securities | Buy |
| Oct-20-22 | Reiterated | DA Davidson | Neutral |
| Oct-20-22 | Reiterated | Evercore ISI | Outperform |
| Oct-20-22 | Reiterated | JP Morgan | Overweight |
| Oct-20-22 | Reiterated | Jefferies | Buy |
| Oct-20-22 | Upgrade | Summit Insights | Hold → Buy |
| Oct-20-22 | Reiterated | Wells Fargo | Equal Weight |
| Jul-25-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-15-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-27-22 | Reiterated | Barclays | Overweight |
| Jan-27-22 | Reiterated | Deutsche Bank | Hold |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | Susquehanna | Neutral |
| Jan-27-22 | Reiterated | UBS | Buy |
| Jan-26-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-12-22 | Reiterated | Barclays | Overweight |
| Jan-10-22 | Reiterated | BofA Securities | Buy |
| Jan-05-22 | Resumed | Jefferies | Buy |
| Dec-15-21 | Reiterated | Deutsche Bank | Hold |
| Oct-21-21 | Reiterated | B. Riley Securities | Buy |
| Oct-21-21 | Downgrade | Summit Insights | Buy → Hold |
| Oct-15-21 | Initiated | Piper Sandler | Neutral |
| Sep-14-21 | Downgrade | Susquehanna | Positive → Neutral |
| Sep-07-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jul-29-21 | Reiterated | Mizuho | Buy |
| Jul-29-21 | Reiterated | Stifel | Buy |
| Jul-29-21 | Reiterated | UBS | Buy |
| Jul-29-21 | Reiterated | Wells Fargo | Equal Weight |
| Mar-31-21 | Initiated | Bernstein | Outperform |
| Jan-28-21 | Reiterated | Cowen | Outperform |
| Jan-08-21 | Downgrade | Needham | Buy → Hold |
| Dec-17-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-22-20 | Reiterated | Goldman | Buy |
| Oct-22-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Oct-22-20 | Reiterated | Mizuho | Buy |
| Oct-22-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-22-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-22-20 | Reiterated | Stifel | Buy |
| Oct-22-20 | Reiterated | UBS | Buy |
| Sep-21-20 | Upgrade | Stifel | Hold → Buy |
| Jul-30-20 | Reiterated | Cowen | Outperform |
| Jul-21-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jun-22-20 | Downgrade | Stifel | Buy → Hold |
| Jun-16-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-26-20 | Initiated | Barclays | Overweight |
| Apr-23-20 | Reiterated | Needham | Buy |
| Apr-08-20 | Initiated | Exane BNP Paribas | Outperform |
| Apr-03-20 | Upgrade | Nomura | Neutral → Buy |
| Apr-02-20 | Downgrade | DA Davidson | Buy → Neutral |
| Mar-27-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-27-20 | Upgrade | UBS | Sell → Buy |
View All
Lam Research Corp Stock (LRCX) Latest News
QRG Capital Management Inc. Decreases Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Nwam LLC - MarketBeat
Lam Research (NASDAQ:LRCX) Trading Up 2.5% After Analyst Upgrade - MarketBeat
Lam Research Unusual Options ActivityLam Research (NASDAQ:LRCX) - Benzinga
Analysts Upgrade Zscaler and Lam Research Ratings, Positive Outlook - Intellectia AI
Wright Investors Service Inc. Invests $1.85 Million in Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Upgraded at Wells Fargo & Company - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Stephens Inc. AR - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $48.19 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
What to expect from Lam Research’s Q2 2025 earnings report - MSN
Lam Research (NASDAQ:LRCX) Given New $225.00 Price Target at Rothschild & Co Redburn - MarketBeat
KLA, ASML, Lam Research, Applied Materials Surge as Chip Stocks Get a Boost - Barron's
Lam Research (NASDAQ:LRCX) Shares Up 4.2% on Analyst Upgrade - MarketBeat
Lobbying Update: $60,000 of LAM RESEARCH CORPORATION lobbying was just disclosed - Quiver Quantitative
Why Lam Research (LRCX) Stock Is Trading Up Today - Finviz
Lam Research (LRCX) Surges 6% on Positive Wafer Equipment Outloo - GuruFocus
Lam Research Corp. (LRCX) Receives Bullish Upgrades with Price Targets Up to $260 - Intellectia AI
TSMC Earnings Reset the AI Narrative After Rotation Fears Hit Tech Stocks - Investing.com
Is Lam Research (LRCX) a Buy as Wall Street Analysts Look Optimistic? - Finviz
B. Riley Adjusts Price Target on Lam Research to $255 From $195, Maintains Buy Rating - marketscreener.com
Lam Research (NASDAQ:LRCX) Sets New 12-Month High After Analyst Upgrade - MarketBeat
LRCX: Wells Fargo Upgrades Lam Research with Significant Price T - GuruFocus
ASML, Lam Research, Applied Materials Surge as Chip Stocks Get a Boost - Barron's
KLA, Lam Research receive upgrades on WFE acceleration: Wells Fargo - Seeking Alpha
Lam Research Soars 165% in a Year: Is LRCX Stock Still a Buy? - Finviz
Here Are Thursday’s Top Wall Street Analyst Research Calls: Applied Materials, BankUnited, Broadcom, Dell Technologies, DraftKings, Lam Research, NVIDIA, and More - 24/7 Wall St.
Why Is Lam Research Stock Rising Premarket Today? - Asianet Newsable
Lam Research Reports Strong Earnings, RBC Initiates Coverage with 25% Upside - Intellectia AI
Conning Inc. Sells 12,335 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 2.6%Here's What Happened - MarketBeat
Lam Research (NASDAQ:LRCX) Price Target Raised to $250.00 at Stifel Nicolaus - MarketBeat
Will LRCX's China Revenue Drop Below 30% Hurt 2026 Growth Outlook? - The Globe and Mail
Kera Capital Partners Inc. Reduces Position in Lam Research Corporation $LRCX - MarketBeat
GRIMES & Co WEALTH MANAGEMENT LLC Takes Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 2.7%Here's What Happened - MarketBeat
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh - Yahoo Finance
Lam Research Corporation (LRCX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Vivid Wealth Management LLC Invests $2.98 Million in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Holdings Boosted by Nordea Investment Management AB - MarketBeat
MGO One Seven LLC Buys 17,514 Shares of Lam Research Corporation $LRCX - MarketBeat
KLA Corporation - Investing.com
Elemental Capital Partners LLC Buys Shares of 48,500 Lam Research Corporation $LRCX - MarketBeat
Lam Research stock rises after-hours as Susquehanna lifts target to $250 - TechStock²
Top Stock Reports for Microsoft, Eli Lilly & Lam Research - Prime Publishers, Inc.
Lam Research (LRCX): Bernstein Raises Price Target to $225 | LRC - GuruFocus
Sumitomo Mitsui Trust Group Inc. Raises Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Meeder Asset Management Inc. - MarketBeat
Tema Etfs LLC Purchases 19,753 Shares of Lam Research Corporation $LRCX - MarketBeat
What to Expect From Lam Research’s Q2 2025 Earnings Report - Barchart.com
Lam Research (LRCX) Needs to "Put Up Plants," Says Jim Cramer - Finviz
Lam Research (LRCX) Needs to “Put Up Plants,” Says Jim Cramer - Insider Monkey
Lam Research Corp Stock (LRCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):